ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial April 04, 2024 Amylyx Pharmaceuticals has announced it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S. following its failure in a late-stage clinical trial. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.